Position in HROW
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$1,385,580
+$102,365 QoQ
Shares Held
32,625
-10.4% QoQ
Ownership
0.087%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#67
of 222 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 12%
Shared 0%
None 88%
Common Shares in HROW Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026JPMORGAN CHASE & CO holds $2,415,050,910 across 61 Drug Manufacturers - Specialty & Generic names. HROW ranks #31 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
6,398,674 | $1,078,432,506 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
6,981,234 | $236,524,202 | |
| 3 | ZTS |
Zoetis Inc.
|
2,624,825 | $188,619,917 | |
| 4 | HIMS |
Hims & Hers Health, Inc.
|
4,766,781 | $165,264,292 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
275,358 | $149,197,220 | |
| 6 | VTRS |
Viatris Inc
|
7,322,267 | $116,277,595 | |
| 7 | HLN |
Haleon plc
|
10,824,395 | $100,991,599 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
699,229 | $77,572,458 |
All Filings in HROW
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,385,580 | 32,625 | Shares | Other | 2026-08-12 | |
| 2026-03-31 | $1,283,215 | 36,393 | Shares | Other | 2026-05-13 | |
| 2025-12-31 | $1,710,443 | 34,907 | Shares | Other | 2026-02-11 | |
| 2025-09-30 | $1,742,524 | 36,167 | Shares | Other | 2025-11-07 | |
| 2025-06-30 | $2,394,731 | 78,413 | Shares | Other | 2025-08-12 | |
| 2025-03-31 | $3,368,383 | 126,631 | Shares | Other | 2025-05-12 | |
| 2024-12-31 | $1,572,720 | 46,877 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $10,716,978 | 238,367 | Shares | Defined | 2024-12-26 | |
| 2024-06-30 | $916,798 | 43,887 | Shares | Defined | 2024-12-26 | |
| 2024-03-31 | $989,126 | 74,764 | Shares | Defined | 2024-12-26 | |
| 2023-12-31 | $1,388,530 | 123,976 | Shares | Defined | 2024-12-26 | |
| 2023-09-30 | $1,110,972 | 77,312 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $1,271,242 | 66,767 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $1,138,048 | 53,783 | Shares | Defined | 2023-05-18 | |
| 2022-12-31 | $925,746 | 62,720 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $895,182 | 74,166 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $584,576 | 80,299 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $632,771 | 92,782 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $915,588 | 105,971 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $958,430 | 105,438 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $1,227,673 | 132,150 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $1,099,000 | 162,815 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $953,298 | 138,965 | Shares | Defined | 2021-02-19 | |
| 2020-09-30 | $548,428 | 98,109 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $355,123 | 68,162 | Shares | Defined | 2020-08-11 | |
| 2020-03-31 | $222,507 | 58,248 | Shares | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||